文献速递肝病

自身免疫性肝病流行病学的最新进展

Recent advances in clinical practice: epidemiology of autoimmune liver diseases.
PubMed 文献 · Gut · 2021-07-15

自身免疫性肝病包括原发性胆汁性胆管炎(PBC)、原发性硬化性胆管炎(PSC)和自身免疫性肝炎(AIH)。综述报告AIH和PSC在欧洲发病率与患病率上升,PBC患病率在欧洲、北美和亚太地区上升,但全球差异显著。尽管疾病罕见,临床负担相对于人群发病率与患病率却不成比例地高。

要点

  • AIH和PSC在欧洲发病率和患病率上升,PBC患病率在欧洲、北美和亚太地区上升。
  • 全球发病率差异显著:PBC为0.84–2.75/10万,PSC为0.1–4.39/10万,AIH为0.4–2.39/10万。
  • 患病率估计:PBC为1.91–40.2/10万,PSC为0.78–31.7/10万,AIH为4.8–42.9/10万。

核心结论

  • 自身免疫性肝病虽罕见,但临床负担相对于人群发病率与患病率不成比例地高。
  • 年龄、性别和种族影响临床结局,患者发病率和死亡率反映在对胃肠病学、肝病学和器官移植服务的高需求上。

研究设计与样本

  • 综述总结了基于人群的研究和多中心观察性队列系列,以了解自身免疫性肝病的流行病学和临床病程。

主要发现

  • AIH和PSC在欧洲发病率与患病率上升,PBC患病率在欧洲、北美和亚太地区上升。
  • 全球发病率差异显著:PBC为0.84–2.75/10万,PSC为0.1–4.39/10万,AIH为0.4–2.39/10万。
  • 患病率估计:PBC为1.91–40.2/10万,PSC为0.78–31.7/10万,AIH为4.8–42.9/10万。
  • 基于人群的研究和多中心观察性队列系列提供了对临床病程的更好理解,突出了地理和时间上表现表型的差异。

关键数值与推荐

  • PBC发病率范围为0.84–2.75/10万,PSC为0.1–4.39/10万,AIH为0.4–2.39/10万。
  • PBC患病率范围为1.91–40.2/10万,PSC为0.78–31.7/10万,AIH为4.8–42.9/10万。

临床怎么用

  • 临床医生应意识到自身免疫性肝病发病率与患病率的变化趋势及全球差异。
  • 年龄、性别和种族影响临床结局,需关注患者对胃肠病学、肝病学和器官移植服务的高需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autoimmune liver diseases are chronic inflammatory hepatobiliary disorders that when classically defined encompass three distinctive clinical presentations; primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). Meaningful changes in disease epidemiology are reported, with increasing incidence and prevalence of AIH and PSC in Europe, and rising prevalence of PBC across Europe, North America and the Asia-Pacific region. However, there appears to be very significant global variation with contemporary incidence rates of disease per 100 000 ranging from 0.84 to 2.75 for PBC, 0.1 to 4.39 for PSC and 0.4 to 2.39 for AIH. Prevalence corresponds, and per 100 000 estimates for PBC range from 1.91 to 40.2, for PSC between 0.78 and 31.7 and for AIH from 4.8 to 42.9. Population-based studies and multicentre observational cohort series provide improved understanding of the clinical course that patients experience, highlighting variations in presenting phenotypes geographically and temporally. Collectively, while autoimmune liver diseases are rare, the clinical burden is disproportionately high relative to population incidence and prevalence. Age, sex and race also impact clinical outcomes, and patient morbidity and mortality are reflected by high need for gastroenterology, hepatology and organ transplant services.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut. 2021. PMID: 34266966. doi:10.1136/gutjnl-2020-322362

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。